Krensavage Asset Management Remains Opposed to Sun Pharma's Predatory Bid for Taro Pharma

Taro Pharmaceutical Industries Ltd. +0.24%

Taro Pharmaceutical Industries Ltd.

TARO

42.52

+0.24%

Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.

Dear Linda,

As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Krensavage Asset Management LLC remains opposed to Sun Pharmaceutical Industries Ltd.'s inadequate bid to take Taro private.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via